1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsFrontiers in Congenital Disorders of Glycosylation Pilot and Feasibility Grants is sponsored by Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC) / CDG CARE. These awards are intended to support projects that will provide preliminary data for new, extramural grant submissions, exclusively focusing on CDG-related science.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Home | Frontiers in Congenital Disorders of Glycosylation A Previously-Funded NIH Rare Diseases Clinical Research Network Consortium Leading research to improve the lives of individuals with congenital disorders of glycosylation Join One of Our Research Studies Participants make it possible for researchers to find new treatments, speed diagnosis, and improve the lives of those affected by Congenital Disorders of Glycosylation (CDG).
Learn About Diseases We Study NIH Announces Funding to Establish and Strengthen Rare Disease Research Groups The National Institutes of Health (NIH) has awarded approximately $26 million in grants in the fiscal year 2025 to begin the fifth cycle of funding for the Rare Diseases Clinical Research Network (RDCRN).
Rare Research Report: August 2025 Each month, we share summaries of recent Rare Diseases Clinical Research Network grant-funded publications. Catch up on RDCRN research for August 2025. $27M Grant Renews Cincinnati Children’s as Coordinating Center for the Rare Diseases Clinical Research Network Cincinnati Children’s will continue as the RDCRN’s Data Management and Coordinating Center for another five years.
According to the current listing, eligibility includes: All basic, translational, or clinical investigators located at institutions within the United States who are eligible to apply as a Principal Investigator for NIH grants. Confirm the full requirements in the official notice before applying.
The current listing shows up to $50,000 in direct costs for each award. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Frontiers in Congenital Disorders of Glycosylation Pilot and Feasibility Grants is funded by Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC) / CDG CARE. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
CDC-RFA-EH-27-0074 posted as a forecast September 22, 2026: 6 expected awards at $750,000 to $900,000. That is flat funding against the expiring cycle — and the only proven way in is the consortium model Arizona used to bring three states under one award.
Read articleThe Rural Health Care Program's Third Further Notice hit the Federal Register on August 31, 2026. It proposes killing cost studies, publishing an eligible services list, setting application processing deadlines, and eliminating the Healthcare Connect Fund annual report. What it conspicuously does not propose is any change to the $744.2 million cap that the whole proceeding says is under strain.
Read articleOn August 7, 2026, Judge Mary S. McElroy vacated HUD's FY2026 Continuum of Care NOFO in full, finding the agency violated the Administrative Procedure Act by skipping notice-and-comment before setting aside roughly $1.3 billion — nearly a third of CoC funding — for new projects. HUD has appealed and been denied an emergency stay. Here is what the ruling actually does to renewals, what Congress already guaranteed, and what CoC leads and subrecipients should be doing during the pause.
Read article